Kava/Hepatotoxicity Link Not Demonstrated By AERs, Toxicologist Says
This article was originally published in The Tan Sheet
Executive Summary
Two AERs involving chronic or high-dose kava consumption, but not liver damage, indicate the supplement may not directly cause hepatotoxicity, Donald Waller, PhD, University of Illinois-Chicago, says in a report submitted to FDA Feb. 19
You may also be interested in...
Kava Labeling Revisions Adopted By Trade Groups; FDA Issues Advisory
Various dietary supplement trade associations adopted revised kava labeling requirements for their member companies following the release of an 1FDA consumer advisory on the botanical
Kava Labeling Revisions Adopted By Trade Groups; FDA Issues Advisory
Various dietary supplement trade associations adopted revised kava labeling requirements for their member companies following the release of an 1FDA consumer advisory on the botanical
Kava Labeling Revisions Adopted By Trade Groups; FDA Issues Advisory
Various dietary supplement trade associations adopted revised kava labeling requirements for their member companies following the release of an 1FDA consumer advisory on the botanical